Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Since the United States seized control of Guam during World War II, the US military has slowly turned the Pacific island into a military garrison, destroying cultural sites, food sources, and ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts say the drug, which is billed as nonaddictive, could reduce the number ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

Common reasons for back pain include muscle strain, disk damage, and some chronic conditions, such as fractures due to osteoporosis. Potential treatments include heat therapy, acupuncture ...

Vertex has set the therapy’s wholesale acquisition cost at $15.50 per 50mg pill. Credit: © 2025 Vertex Pharmaceuticals Incorporated. All Rights Reserved. The US ...